C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/31 (2006.01) A23L 1/48 (2006.01) A61K 39/102 (2006.01) C07K 14/285 (2006.01) C12N 1/20 (2006.01) C12N 15/74 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2303390
Mutants of P. haemolytica provide excellent safety and efficacy when used as vaccines in ruminants, for example cattle, sheep, and goats, subject to pneumonic pasteurellosis. They can be administered by a variety of routes. Especially preferred is the use in animal feeds. The mutants are not reverting and contain no foreign DNA and no introduced antibiotic resistance genes.
Des mutants de P. Haemolytica présentent une excellente sécurité et une excellente efficacité lorsqu'on les utilise en tant que vaccins chez des ruminants, par exemple des boeufs, des moutons et des chèvres sujets à la pasteurellose bovine. On peut les administrer par diverses voies. L'utilisation idéale est dans les aliments pour animaux. Les mutants ne présentent pas de réversion et ils ne contiennent pas d'ADN étranger ni de gènes de résistance aux antibiotiques introduits.
Briggs Robert E.
Tatum Fred M.
Biotechnology Research And Development Corporation
Deeth Williams Wall Llp
United States Of America As Represented By The Secretary Of Agri
LandOfFree
Lkta deletion mutant of p. haemolytica does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lkta deletion mutant of p. haemolytica, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lkta deletion mutant of p. haemolytica will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1893254